デフォルト表紙
市場調査レポート
商品コード
1466692

核医学市場:製品、用途、タイプ、エンドユーザー別-2024-2030年の世界予測

Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
核医学市場:製品、用途、タイプ、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

核医学市場規模は2023年に51億4,000万米ドルと推計され、2024年には55億1,000万米ドルに達し、CAGR 7.35%で2030年には84億5,000万米ドルに達すると予測されています。

核医学市場とは、医療用画像診断と治療のための放射性同位元素の使用と生産に関係するヘルスケア産業を指します。核医学市場には、陽電子放射断層撮影法(PET)や単光子放射断層撮影法(SPECT)などの画像診断に使用される診断用放射性医薬品や、さまざまな疾患の治療に使用される治療用放射性医薬品が含まれます。イメージング技術の進歩と新しい放射性医薬品の開発が市場開拓に影響を与えています。精密な診断技術を必要とする慢性疾患の有病率の上昇が、核医学の必要性を高めています。患者やヘルスケアプロバイダーの核医学に対する認識と受容の高まりが市場成長に寄与しています。しかし、厳しい規制障壁や製品開発コストの高さが、核医学の採用を制限しています。画像診断機器や専門施設に必要な高額な設備投資が市場の課題となっています。さらに、より安全で有効性の高い新規放射性同位元素の製造が、市場成長の大きな機会を引き寄せています。核剤に診断と治療の機能を統合したセラノスティクスの出現も、市場の成長可能性を生み出しています。

主な市場の統計
基準年[2023] 51億4,000万米ドル
予測年[2024] 55億1,000万米ドル
予測年 [2030] 84億5,000万米ドル
CAGR(%) 7.35%

製品核医学における診断用製品の意義

核医学における診断用製品は、主に体内に導入された放射性トレーサーからの放射線を検出することにより、様々な疾患の診断と管理に使用されます。診断用トレーサーは特定の臓器、骨、組織をターゲットとするため、医師は身体の一部がどのように機能しているかを確認し、異常を発見することができます。核医学に含まれる治療用製品は、様々ながんやその他の疾患を治療するために設計されています。核医学に含まれる治療用製品は、正常組織へのダメージを最小限に抑えながら、疾患細胞を特異的に標的として破壊する放射性同位元素を含む放射性医薬品を含んでいます。

エンドユーザー病院や診断センターにおける多様な用途

病院および診断センターは、核医学市場において最大のエンドユーザーです。病院や診断センターは、正確で迅速な患者ケアを提供するために、診断画像や標的治療アプリケーションを必要としています。研究機関は、新しい放射性医薬品、新しいイメージング技術、最先端の治療法を探求することで、核医学の発展に大きく貢献しています。

地域別インサイト

米国とカナダを含む南北アメリカ地域では、高度なヘルスケアインフラ、高い医療費、放射性医薬品の豊富なパイプラインが核医学の需要を牽引しています。米国とカナダは、先進的診断法の早期導入、研究開発への多額の投資、有利な償還政策により、依然として核医学の最大地域です。欧州市場は高度な経済発展、確立されたヘルスケアシステム、多額の政府資金を特徴としています。欧州地域では、診断用・治療用放射性医薬品に対する需要は、コスト抑制策とエビデンスに基づく臨床転帰の重視によってバランスが取れています。中東地域では、アラブ首長国連邦(UAE)とサウジアラビアが主要な貢献国であり、核医療サービスへのアクセスを向上させる取り組みで市場成長に寄与しています。APAC地域では、中国の核医学分野が、ヘルスケア・インフラへの政府投資とがんおよび心血管疾患の罹患率の増加により急速に拡大しています。日本とインドの核医学分野は、医療意識の高まりと医療施設の改善により成長しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは核医学市場を評価する上で極めて重要です。事業戦略や製品満足度に関する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、核医学市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.核医学市場の市場規模および予測は?

2.核医学市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.核医学市場の技術動向と規制枠組みは?

4.核医学市場における主要ベンダーの市場シェアは?

5.核医学市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中でがんの発生率と罹患率が上昇
      • 心臓病や神経疾患の診断におけるPETとSPECTの使用増加
      • 国際機関の取り組みと意識支援核医学
    • 抑制要因
      • 核医学の半減期が短い
    • 機会
      • 核医学におけるセラノスティクスの人気の高まり
      • 継続的な製品開発と特許技術の進歩
    • 課題
      • 新興諸国における核医学に関する知識、トレーニング、利用可能性の不足
      • 世界中で熟練した放射線科医と医師の不足
  • 市場セグメンテーション分析
    • 製品:核医学における診断製品の意義
    • エンドユーザー:病院や診断センターでの多様な用途
  • 市場動向分析
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析
  • 顧客のカスタマイズ

第6章 核医学市場:製品別

  • 診断製品
  • 治療製品

第7章 核医学市場:用途別

  • 骨転移
  • 心臓病学
  • 内分泌腫瘍
  • リンパ腫
  • 腫瘍学
  • 甲状腺

第8章 核医学市場:タイプ別

  • 診断
  • 治療的

第9章 核医学市場:エンドユーザー別

  • 病院と診断センター
  • 調査機関

第10章 南北アメリカの核医学市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の核医学市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの核医学市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • Shine、Nucleus RadioPharmaと供給契約を締結
    • ITMとカナダ原子力研究所が新会社を設立
    • ライフヘルスケア、南アフリカの核医学事業を買収へ

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NUCLEAR MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 108. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 109. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 110. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 111. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 112. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 113. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 114. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 115. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 116. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 117. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 118. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 119. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 124. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 125. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 126. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 127. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 128. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 129. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 134. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 135. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 136. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 137. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 138. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 139. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 140. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 141. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 142. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 143. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 144. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 145. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 150. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 151. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 152. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 153. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 158. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 159. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 160. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 161. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 162. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 163. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 164. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 165. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 166. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 167. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 168. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 169. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 174. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 175. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 176. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 177. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 178. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 179. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 182. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 183. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 184. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 185. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 186. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 187. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 188. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 189. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 190. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 191. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 192. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 193. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 198. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 199. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 200. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 201. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 202. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 203. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 206. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 207. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 208. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 209. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 210. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 211. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 212. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 213. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 214. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 215. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 216. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 217. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 222. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 223. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 224. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 225. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 226. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 227. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 230. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 231. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 232. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 233. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 234. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 235. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 236. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 237. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 238. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 239. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 240. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 241. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 246. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 247. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 248. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 249. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 250. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 251. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 252. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 279. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 282. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 283. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 284. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 285. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 286. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 287. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 288. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 289. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 290. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 291. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 292. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 293. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 298. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 299. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 300. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 301. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 302. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 303. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 306. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 307. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 308. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 309. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 310. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 311. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 312. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 313. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 314. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 315. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 316. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 317. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 322. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 323. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 324. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 325. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 326. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 327. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 330. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 331. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 332. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 333. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 334. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 335. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 336. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 337. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 338. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 339. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 340. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 341. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 346. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 347. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 348. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 349. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 350. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 351. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 354. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 355. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 356. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 357. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 358. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 359. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 360. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 361. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 362. I
目次
Product Code: MRR-A339DAEFAF4C

[184 Pages Report] The Nuclear Medicine Market size was estimated at USD 5.14 billion in 2023 and expected to reach USD 5.51 billion in 2024, at a CAGR 7.35% to reach USD 8.45 billion by 2030.

The nuclear medicine market refers to the healthcare industry concerned with the use and production of radioisotopes for medical imaging and therapy. The nuclear medicine market includes diagnostic radiopharmaceuticals used in imaging procedures including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as therapeutic radiopharmaceuticals for the treatment of various conditions. The advancements in imaging technologies and the development of new radiopharmaceuticals is influencing the market growth. The rising prevalence of chronic diseases requiring precise diagnostic techniques is enhancing the need for nuclear medicines. The increased awareness and acceptance of nuclear medicine procedures among patients and healthcare providers is contributing to market growth. However, stringent regulatory barriers and the high cost of product development has limited the adoption of nuclear medicines. High capital investment required for imaging equipment and specialized facilities is a challenging factor for the market. Moreover, manufacturing of novel radioisotopes with safer profiles and higher efficacy is attracting significant opportunities for market growth. The emergence of theranostics, integrating diagnostic and therapeutic capabilities within nuclear agents is also generating growth potential in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 5.14 billion
Estimated Year [2024] USD 5.51 billion
Forecast Year [2030] USD 8.45 billion
CAGR (%) 7.35%

Product: Significance of diagnostic products in nuclear medicines

Diagnostic products in nuclear medicine are primarily used to diagnose and manage various diseases by detecting the radiation from a radioactive tracer that is introduced into the body. Diagnostic tracers target specific organs, bones, or tissues, allowing physicians to see how body parts function and detect anomalies. Therapeutic products in nuclear medicine are designed to treat various cancers and other diseases. Therapeutic products in nuclear medicine involve radiopharmaceuticals containing radioactive isotopes that specifically target and destroy diseased cells while minimizing damage to normal tissues.

End-Users: Diverse applications in hospitals and diagnostic centers

The hospitals, and diagnostic centers represent the largest end-user segment in the nuclear medicine market. Hospitals & diagnostic centers need diagnostic imaging and targeted therapeutic applications to provide accurate and prompt patient care. Research institutes significantly contribute to advancing nuclear medicine by exploring new radiopharmaceuticals, novel imaging techniques, and cutting-edge therapeutic methods.

Regional Insights

In the Americas region, the United States and Canada, the demand for nuclear medicine is driven by a sophisticated healthcare infrastructure, high healthcare expenditure, and a robust pipeline of radiopharmaceuticals. The United States and Canada remain the largest region for nuclear medicine due to its early adoption of advanced diagnostics, substantial investment in research and development, and favorable reimbursement policies. The European market is characterized by a high level of economic development, a well-established healthcare system, and significant government funding. In the European region, the demand for diagnostic and therapeutic radiopharmaceuticals is balanced by cost-containment measures and emphasis on evidence-based clinical outcomes. The United Arab Emirates (UAE) and Saudi Arabia are key contributors in the Middle East region, contributing to the market growth, with initiatives to increase accessibility to nuclear medical services. In the APAC region, china's nuclear medicine sector is rapidly expanding, due to government investment in healthcare infrastructure and an increasing incidence of cancer and cardiovascular diseases. Japan and India's nuclear medicine sector is growing due to rising healthcare awareness and improvements in healthcare facilities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nuclear Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nuclear Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BJ Madan & Co., Bracco S.p.A., BWX Technologies, Inc. by Framatome, Cardinal Health, Inc., Curium, Eckert & Ziegler Radiopharma GmbH, Eczacibasi Monrol Nuclear Products Co., GE Healthcare, IBA Radiopharma Solutions, Institute of Isotopes Co., Ltd., Isotope Joint Stock Company, Isotopia Molecular Imaging, Jubilant DraxImage, Inc., Lantheus Holdings, Inc., Nordic Nanovector ASA by Thor Medical, Nordion (Canada) Inc. by Sotera Health LLC, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, Radiopharm Theranostics Limited, SHINE Technologies, LLC, and Sinotau Pharmaceuticals Group.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Diagnostic Products
      • PET
        • F-18
        • SR-82/RB-82
      • SPECT
        • GA-67
        • I-123
        • TC-99m
        • TL-201
    • Therapeutic Products
      • Alpha Emitters
      • Beta Emitters
        • I-131
        • Lu-117
        • Re-186
        • SM-153
        • Y-90
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Iridium-192
        • Palladium-103
  • Application
    • Bone Metastasis
    • Cardiology
    • Endocrine Tumor
    • Lymphoma
    • Oncology
    • Thyroid
  • Type
    • Diagnostic
      • PET Procedures
      • SPECT Procedures
    • Therapeutic
      • Alpha Emitter Procedures
      • Beta Emitter Procedures
      • Brachytherapy Procedures
  • End-Users
    • Hospitals & Diagnostic Centers
    • Research institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nuclear Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nuclear Medicine Market?

3. What are the technology trends and regulatory frameworks in the Nuclear Medicine Market?

4. What is the market share of the leading vendors in the Nuclear Medicine Market?

5. Which modes and strategic moves are suitable for entering the Nuclear Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
      • 5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
      • 5.1.1.3. International Organizations' Initiatives and Awareness Supporting Nuclear Medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Shorter Half-Life of Nuclear Medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
      • 5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
      • 5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significance of diagnostic products in nuclear medicines
    • 5.2.2. End-Users: Diverse applications in hospitals and diagnostic centers
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Nuclear Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Products
  • 6.3. Therapeutic Products

7. Nuclear Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Cardiology
  • 7.4. Endocrine Tumor
  • 7.5. Lymphoma
  • 7.6. Oncology
  • 7.7. Thyroid

8. Nuclear Medicine Market, by Type

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Therapeutic

9. Nuclear Medicine Market, by End-Users

  • 9.1. Introduction
  • 9.2. Hospitals & Diagnostic Centers
  • 9.3. Research institutes

10. Americas Nuclear Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nuclear Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nuclear Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Shine Reaches Supply Agreement with Nucleus RadioPharma
    • 13.3.2. ITM and Canadian Nuclear Labs Launch New Company
    • 13.3.3. Life Healthcare Set to Acquire Nuclear-medicine Operation in SA

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio